| Product Code: ETC7536829 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Apixaban Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Apixaban Market Revenues & Volume, 2021 & 2031F |
3.3 India Apixaban Market - Industry Life Cycle |
3.4 India Apixaban Market - Porter's Five Forces |
3.5 India Apixaban Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.6 India Apixaban Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.7 India Apixaban Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Apixaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in India |
4.2.2 Growing awareness about the benefits of using apixaban for stroke prevention |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in India |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for new drugs in India |
4.3.2 Competition from other anticoagulant drugs in the market |
4.3.3 Lack of awareness among healthcare professionals about the efficacy of apixaban |
5 India Apixaban Market Trends |
6 India Apixaban Market, By Types |
6.1 India Apixaban Market, By Dosage Form |
6.1.1 Overview and Analysis |
6.1.2 India Apixaban Market Revenues & Volume, By Dosage Form, 2021- 2031F |
6.1.3 India Apixaban Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.4 India Apixaban Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2 India Apixaban Market, By End-Users |
6.2.1 Overview and Analysis |
6.2.2 India Apixaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Apixaban Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 India Apixaban Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 India Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Apixaban Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Apixaban Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 India Apixaban Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 India Apixaban Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 India Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
7 India Apixaban Market Import-Export Trade Statistics |
7.1 India Apixaban Market Export to Major Countries |
7.2 India Apixaban Market Imports from Major Countries |
8 India Apixaban Market Key Performance Indicators |
8.1 Number of new patients prescribed apixaban for stroke prevention |
8.2 Percentage increase in the adoption of apixaban compared to other anticoagulant drugs |
8.3 Rate of growth in the number of healthcare providers recommending apixaban for cardiovascular disease management |
9 India Apixaban Market - Opportunity Assessment |
9.1 India Apixaban Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.2 India Apixaban Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.3 India Apixaban Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Apixaban Market - Competitive Landscape |
10.1 India Apixaban Market Revenue Share, By Companies, 2024 |
10.2 India Apixaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here